Register to get free articles
Want unlimited access? View Plans
Already have an account? Sign in
Interpath has appointed Adam Thorpe as managing director and head of deal strategy, as it expands support for organisations and investors seeking to accelerate growth and improve performance.
Thorpe joins from deal strategy consultancy Stax, bringing more than 30 years of experience in professional services and a track record of leading over 500 projects in deal and growth strategy.
He previously founded and led KPMG’s French strategy practice between 2000 and 2015, before heading deal strategy in healthcare at KPMG UK.
Over the past two decades, Thorpe has developed extensive experience in the health, care and life sciences sectors, advising clients across sub-sectors including care services, medical devices, diagnostics, life sciences and education.
At Interpath, he will focus on commercial due diligence, strategic growth planning and performance improvement.
Nathan McCarthy, global head of strategy and value creation at Interpath, said: “Our strategy and value creation practice takes leadership teams through complex change initiatives to deliver measurable improvements in cash, cost and margin. Adam’s arrival marks a significant step in the evolution of the offering, deepening our integration with our deals colleagues to help clients steer strategy through the full deal lifecycle.
“It’s incredibly exciting to join such a dynamic and fast-growing team that’s challenging the status quo in professional services. This role is about supporting our corporate and private equity clients in bringing to life the equity story and value creation potential of a business, to attract investment, secure capital and drive strategic growth.”
